Index

Prof.Dr. Peter Gmeiner 
Chair of Medicinal Chemistry
Chemikum
Nikolaus-Fiebiger-Str. 10
D-91058 Erlangen

Room: 02.237
peter.gmeiner@fau.de
Tel.: +49-(0)9131-85-65547
       +49-(0)9131-85-65594

Publications

Ursula Bodinus

Room: 04.059
ursula.bodinus@fau.de
Tel.: +49-(0)9131-85-65595

Andrea Meixner-Wolf

Room: 04.058
andrea.meixner-wolf@fau.de
Tel.: +49-(0)9131-85-65594

Dr. Jürgen Einsiedel

Room: 02.2236
juergen.einsiedel@fau.de
Tel.: +49-(0)9131-85-65545

Dr. Harald Hübner

Room: 02.218
harald.huebner@fau.de
Tel.: +49-(0)9131-85-65528

Dr. Stefan Löber

Room: 04.065
stefan.loeber@fau.de
Tel.: +49-(0)9131-85-65602

Dr. Dorothée Weikert

Room: 04.019
dorothee.weikert@fau.de
Tel.: +49-(0)9131-85-65565

Weikert Lab

Omed Akreyi

Room: 02.225
omed.akreyi@fau.de
Tel.: +49-(0)9131-85-65535

Forschungsgebiet: t.b.a.

Prof. Dr. Peter Gmeiner (*30.05.1959) received his Ph.D. in 1986 from the University of Munich. From 1987 to 1988 he was a postdoc at the University of California in Berkeley, USA. He subsequently returned to Munich as a research associate at the Institute of Pharmaceutical Chemistry. Upon receiving his Dr. habilitus in 1992, for which he was honored with the Johann-Wolfgang-Döberreiner prize of the DPhG (1993), he was appointed at the University of Bonn as a Professor of Pharmaceutical Chemistry declining an offer for a professorship at the University of Heidelberg, at the same time. Since October 1996, he has been chaired Full Professor of Pharmaceutical / Medicinal Chemistry at the Friedrich-Alexander University Erlangen-Nürnberg (FAU). In 2000, he declined an offer for the Chair of Pharmaceutical Chemistry at the University of Münster. From 2000 to 2002, he was a Senator at FAU. 2003-2010, he was a board member of the Medicinal Chemistry Section of the German Chemical Society (GDCh). 2008-2019, Peter Gmeiner has been chairman of the Pharmaceutical / Medicinal Chemistry Section of the German Pharmaceutical Society (DPhG). 2008-2012, he was the speaker of the Emil Fischer Graduate Programme in Pharmaceutical Sciences & Molecular Medicine (EFS). 2017-2019, Peter Gmeiner has been the Chairman of the Department of Chemistry and Pharmacy and Vice-Dean of the Faculty of Natural Science. Peter Gmeiner has been the spokesman of the Research Training Group „Medicinal Chemistry of Selective GPCR Ligands“ (GRK 1910). Peter Gmeiner is a co-founder and consultant of the company Epiodyne, Inc and a recipient of a Reinhart Koselleck Programme grant from the German Research Foundation (DFG).

Das Ziel der Pharmazeutischen Chemie (Medicinal Chemistry) ist die Entdeckung neuer, effektiverer Wirkstoffe (Drug Discovery). Sie umfasst chemische Synthese, biologische Testung, Struktur-Wirkungsbeziehungen und Untersuchungen zum molekularen Wirkungsmechanismus (z.B. Mutagenese Studien, Molecular Modelling). In Erlangen bildet die Kombination der Pharmazeutischen Chemie mit der verfahrenstechnisch / biopharmazeutisch orientierten Pharmazeutischen Technologie (Pharmaceutics) und der bioanalytisch ausgerichteten Lebensmittelchemie (Food Chemistry) eine molekulare Brücke zwischen Medizinischer und Technischer Fakultät.

---

Aiming to discover novel, highly effective drugs (drug discovery), Medicinal Chemistry integrates chemical synthesis, biological testing, structure-activity relationships and investigations on the molecular mechanism of action (e.g. mutagenesis studies, molecular modelling). In Erlangen, the combination of Medicinal Chemistry with the procedural / biopharmaceutically oriented Pharmaceutics and the bioanalytically focussed Food Chemistry forms a Molecular Bridge between the Medical and the Technical Faculty.